"Cell Survival" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.
| Descriptor ID |
D002470
|
| MeSH Number(s) |
G04.346
|
| Concept/Terms |
Cell Survival- Cell Survival
- Survival, Cell
- Cell Viability
- Cell Viabilities
- Viabilities, Cell
- Viability, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Survival".
Below are MeSH descriptors whose meaning is more specific than "Cell Survival".
This graph shows the total number of publications written about "Cell Survival" by people in this website by year, and whether "Cell Survival" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 4 | 4 |
| 1997 | 1 | 5 | 6 |
| 1998 | 0 | 11 | 11 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 6 | 6 |
| 2002 | 0 | 9 | 9 |
| 2003 | 0 | 17 | 17 |
| 2004 | 2 | 14 | 16 |
| 2005 | 0 | 12 | 12 |
| 2006 | 2 | 21 | 23 |
| 2007 | 5 | 23 | 28 |
| 2008 | 2 | 26 | 28 |
| 2009 | 3 | 24 | 27 |
| 2010 | 1 | 17 | 18 |
| 2011 | 0 | 31 | 31 |
| 2012 | 0 | 33 | 33 |
| 2013 | 0 | 25 | 25 |
| 2014 | 1 | 26 | 27 |
| 2015 | 1 | 32 | 33 |
| 2016 | 2 | 41 | 43 |
| 2017 | 0 | 33 | 33 |
| 2018 | 1 | 34 | 35 |
| 2019 | 1 | 22 | 23 |
| 2020 | 1 | 26 | 27 |
| 2021 | 0 | 15 | 15 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 4 | 4 |
| 2024 | 3 | 11 | 14 |
| 2025 | 0 | 15 | 15 |
| 2026 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Survival" by people in Profiles.
-
Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer. Anticancer Res. 2026 May; 46(5):2445-2453.
-
CHK1 is an integral regulator of DNA replication in human cells. Cell Death Dis. 2026 Mar 26; 17(1).
-
Evaluation of in Vitro Cytotoxicity and Induction Potential of A?a? (Euterpe oleracea) Extracts in Human Hepatocytes. J Diet Suppl. 2026; 23(2):217-239.
-
Evaluating the Antiproliferative Effects of Tri(2-Furyl)- and Triphenylphosphine-Gold(I) Pyridyl- and Pyrimidine-Thiolate Complexes. Biomolecules. 2026 Jan 15; 16(1).
-
Dinaciclib improves treatment response in chemoresistant hepatoblastoma. Sci Rep. 2025 Dec 05; 16(1):1410.
-
Retinal Ischemia: Therapeutic Effects and Mechanisms of Paeoniflorin. Int J Mol Sci. 2025 Nov 11; 26(22).
-
Posthumous sperm retrieval in the context of armed conflict. Hum Reprod. 2025 Nov 01; 40(11):2056-2065.
-
Antibiotic treatment limits survival of peripheral and bone marrow B-cell populations. Blood Adv. 2025 Oct 14; 9(19):5056-5069.
-
Thioridazine induces phospholipid accumulation and necroptosis in parental and tamoxifen-resistant breast cancer cells. Mol Omics. 2025 Sep 22; 21(5):496-511.
-
Comparison of the Cytotoxicity, Internalization and Anti-Cancer Drug Delivery Efficacy of Nature Killer Cell Derived Nanovesicles and Extracellular Vesicles. Int J Nanomedicine. 2025; 20:10683-10700.